No Result
View All Result
  • Home
  • Stock Watchlist
  • Stock Analyst News
  • Earning News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Retail Trade
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Retail Trade Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
healthtechmovers.com
No Result
View All Result

This Week's HealthTech Earnings Report: Read Now (April 19th)

by Staff Editor
Apr 19, 2022
in Health Pot Stock Health Technology Health Services Earnings 

April 19th, 2022 (Earnings Report)

Dear Reader,

We just identified several healthtech stocks that are expected to release earnings this week.

If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.

Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.


Johnson & Johnson
Symbol: JNJ
Recent Price: $177.66
Average Analyst Price Target: $188.73 (6.23%)
Market Cap: $467.18B
Last Year's EPS: $2.59
Consensus EPS Forecast: $2.58
Expected Earnings Date: Apr 18 2022

Recent Analyst Action: Jayson Bedford, analyst at Raymond James, reiterates coverage on Johnson & Johnson (JNJ) in the Healthcare sector with a Buy rating and a price target of $ 195 (5 days ago). 

TipRanks.com also reports that Johnson & Johnson currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $188.73 . The target pricing ranges from a high forecast of $215.00 down to a low forecast of $173.00. Johnson & Johnson (JNJ)’s last closing price was $177.66 which would put the average price target at 6.23% upside.

Here are 3rd party ratings for JNJ:

  • TipRanks.com: Moderate Buy
  • TradingView.com: Neutral
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Strong buy
  • Zacks.com: Hold, Top 36% (92 out of 253)
Click for chart >>
--------------------------------------------------------------------------

Rubicon Organics
Symbol: ROMJF
Recent Price: $0.98
Average Analyst Price Target: $2.77 (182.65%)
Market Cap: $54.86M
Last Year's EPS: -$0.06
Consensus EPS Forecast: ―
Expected Earnings Date: Apr 17 2022

Recent Analyst Action: Rahul Sarugaser, analyst at Raymond James, reiterates coverage on Rubicon Organics (ROMJF) in the Healthcare sector with a Buy rating and a price target of $ 2.77 (1 day ago). 

TipRanks.com also reports that Rubicon Organics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.77 . The target pricing ranges from a high forecast of $2.77 down to a low forecast of $2.77. Rubicon Organics (ROMJF)’s last closing price was $0.98 which would put the average price target at 182.65% upside.

Here are 3rd party ratings for ROMJF:

  • TipRanks.com: Moderate Buy
  • TradingView.com: n/a
  • Yahoo! Finance: Neutral Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: n/a, n/a
Click for chart >>
--------------------------------------------------------------------------

Abbott Labs
Symbol: ABT
Recent Price: $116.29
Average Analyst Price Target: $143.22 (23.16%)
Market Cap: $205.08B
Last Year's EPS: $1.32
Consensus EPS Forecast: $1.47
Expected Earnings Date: Apr 19 2022

Recent Analyst Action: Larry Biegelsen, analyst at Wells Fargo, reiterates coverage on Abbott Labs (ABT) in the Healthcare sector with a Buy rating and a price target of $ 150 (1 week ago). 

TipRanks.com also reports that Abbott Labs currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $143.22 . The target pricing ranges from a high forecast of $151.00 down to a low forecast of $138.00. Abbott Labs (ABT)’s last closing price was $116.29 which would put the average price target at 23.16% upside.

Here are 3rd party ratings for ABT:

  • TipRanks.com: Strong Buy
  • TradingView.com: Strong Sell
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Hold, Bottom 39% (154 out of 253)
Click for chart >>
--------------------------------------------------------------------------

Anthem
Symbol: ANTM
Recent Price: $512.95
Average Analyst Price Target: $495.00 (-3.50%)
Market Cap: $123.74B
Last Year's EPS: $7.01
Consensus EPS Forecast: $7.85
Expected Earnings Date: Apr 19 2022

Recent Analyst Action: Ann Hynes, analyst at Mizuho Securities, reiterates coverage on Anthem (ANTM) in the Healthcare sector with a Buy rating and a price target of $ 510 (1 week ago). 

TipRanks.com also reports that Anthem currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $495.00 . The target pricing ranges from a high forecast of $590.00 down to a low forecast of $335.00. Anthem (ANTM)’s last closing price was $512.95 which would put the average price target at -3.50% upside.

Here are 3rd party ratings for ANTM:

  • TipRanks.com: Strong Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong buy
  • Zacks.com: Hold, Top 33% (83 out of 253)
Click for chart >>
--------------------------------------------------------------------------

Imac Holdings
Symbol: IMAC
Recent Price: $0.8301
Average Analyst Price Target: n/a ()
Market Cap: $21.99M
Last Year's EPS: -$0.15
Consensus EPS Forecast: ―
Expected Earnings Date: Apr 19 2022

Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on Imac Holdings (IMAC) in the Healthcare sector with a Hold rating and a price target of n/a (3 weeks ago). 

TipRanks.com also reports that Imac Holdings currently has n/a analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is n/a . The target pricing ranges from a high forecast of n/a down to a low forecast of n/a. Imac Holdings (IMAC)’s last closing price was $0.8301 which would put the average price target at  upside.

Here are 3rd party ratings for IMAC:

  • TipRanks.com: Hold
  • TradingView.com: Sell
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Hold, Bottom 31% (174 out of 253)
Click for chart >>
--------------------------------------------------------------------------

Oxford BioMedica
Symbol: OXBDF
Recent Price: $8.35
Average Analyst Price Target: $24.74 (196.29%)
Market Cap: $802.14M
Last Year's EPS: <$0.01
Consensus EPS Forecast: $0.11
Expected Earnings Date: Apr 19 2022

Recent Analyst Action: Charles Weston, analyst at RBC Capital, reiterates coverage on Oxford BioMedica (OXBDF) in the Healthcare sector with a Buy rating and a price target of $ 18.17 (3 weeks ago). 

TipRanks.com also reports that Oxford BioMedica currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $24.74 . The target pricing ranges from a high forecast of $31.31 down to a low forecast of $18.17. Oxford BioMedica (OXBDF)’s last closing price was $8.35 which would put the average price target at 196.29% upside.

Here are 3rd party ratings for OXBDF:

  • TipRanks.com: Moderate Buy
  • TradingView.com: n/a
  • Yahoo! Finance: Neutral Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Hold, Bottom 39% (154 out of 253)
Click for chart >>
--------------------------------------------------------------------------

Tenet Healthcare
Symbol: THC
Recent Price: $84.15
Average Analyst Price Target: $105.29 (25.12%)
Market Cap: $9.19B
Last Year's EPS: $1.3
Consensus EPS Forecast: $1.01
Expected Earnings Date: Apr 19 2022

Recent Analyst Action: Whit Mayo, analyst at Leerink Partners, reiterates coverage on Tenet Healthcare (THC) in the Healthcare sector with a Buy rating and a price target of $ 100 (5 days ago). 

TipRanks.com also reports that Tenet Healthcare currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $105.29 . The target pricing ranges from a high forecast of $125.00 down to a low forecast of $89.00. Tenet Healthcare (THC)’s last closing price was $84.15 which would put the average price target at 25.12% upside.

Here are 3rd party ratings for THC:

  • TipRanks.com: Strong Buy
  • TradingView.com: Sell
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: buy
  • Zacks.com: Hold, Top 30% (76 out of 253)
Click for chart >>
--------------------------------------------------------------------------


To Your Financial Future,

The Editor, HealthTechMovers.com

Tags: JNJ ANTM THC HealthTech Earnings ROMJF 

Related Posts

Utilities stock watchlist Utilities stocks Utilities stock movers Phillips 66 stock PSX 

Barclays Analyst Reiterates Buy Rating on Phillips 66, PSX Stock

Jul 06, 2022
Utilities stock watchlist Utilities stocks Utilities stock movers energy stocks Ranger Oil stock 

RBC Capital Analyst Reiterates Buy Rating on Ranger Oil, ROCC Stock

Jul 06, 2022
Utilities stock watchlist Utilities stocks Utilities stock movers EQT stock EQT 

Citigroup Analyst Reiterates Buy Rating on EQT, EQT Stock

Jul 06, 2022
Utilities stock watchlist Utilities stocks Utilities stock movers Conocophillips stock COP 

Mizuho Securities Analyst Reiterates Buy Rating on Conocophillips, COP Stock

Jul 06, 2022
Utilities stock watchlist Utilities stocks Utilities stock movers Northern Oil And Gas stock NOG 

RBC Capital Analyst Reiterates Buy Rating on Northern Oil And Gas, NOG Stock

Jul 06, 2022
Utilities stock watchlist Utilities stocks Utilities stock movers XOM XOM price target 

Wells Fargo Analyst Reiterates Buy Rating on Exxon Mobil, XOM Stock

Jul 06, 2022
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Stock Market Today by TradingView

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Sitemap
  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Privacy Policy
  • Disclaimer

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Retail Trade
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In